SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-313801
Filing Date
2020-12-09
Accepted
2020-12-09 16:02:14
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 d69540d424b5.htm 424B5 432482
2 GRAPHIC g69540g46z71.jpg GRAPHIC 64159
3 GRAPHIC g69540g52l40.jpg GRAPHIC 62106
4 GRAPHIC g69540g54m52.jpg GRAPHIC 111348
5 GRAPHIC g69540g54w48.jpg GRAPHIC 60084
6 GRAPHIC g69540g63z99.jpg GRAPHIC 110641
  Complete submission text file 0001193125-20-313801.txt   996696
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233564 | Film No.: 201377870
SIC: 2834 Pharmaceutical Preparations